a year ago
SRPT
AnalystsMitchell KapoorMitchell Kapoor's Stock Forecasts
AnalystsMitchell Kapoor
Sectors:
Industries:
Analyst Ranking
Top 6%
#265 out of 5185 analysts
Average Return
+11.08%
Win Rate
41%133 out of 321
Risk vs Reward
Poor
Good
Mitchell Kapoor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alumis IncALMS | +586.55% | $3.57 | $24.51 | 2025-03-20 - 2026-01-30 | Buy |
Alumis IncALMS | +531.70% | $3.88 | $24.51 | 2025-07-25 - 2026-01-30 | Buy |
Alumis IncALMS | +492.03% | $4.14 | $24.51 | 2025-04-30 - 2026-01-30 | Buy |
Alumis IncALMS | +439.87% | $4.54 | $24.51 | 2025-03-03 - 2026-01-30 | Buy |
Alumis IncALMS | +411.69% | $4.79 | $24.51 | 2025-03-11 - 2026-01-30 | Buy |
Mitchell Kapoor Analyst Color
Get additional color on Mitchell Kapoor's coverage of popular stocks
a year ago
SRPT
a year ago
SMMT
Mitchell Kapoor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Crispr Therapeutics AgCRSP | 5 | Buy | $80.00 | +60.13% | Maintains | 6 months ago |
Halozyme Therapeutics IncHALO | 36 | Buy | $75.00 | +4.59% | Maintains | 6 months ago |
Ionis Pharmaceuticals IncIONS | 5 | Buy | $65.00 | -21.37% | Maintains | 6 months ago |
Alumis IncALMS | 13 | Buy | $14.00 | -42.88% | Reiterates | 6 months ago |
Korro Bio IncKRRO | 13 | Buy | $100.00 | +650.19% | Reiterates | 6 months ago |
Oruka Therapeutics IncORKA | 6 | Buy | $45.00 | +31.46% | Reiterates | 6 months ago |
Legend Biotech CorpLEGN | 39 | Buy | $75.00 | +328.57% | Reiterates | 7 months ago |
Tyra Biosciences IncTYRA | 20 | Buy | $30.00 | -2.66% | Reiterates | 7 months ago |
Summit Therapeutics IncSMMT | 14 | Buy | $44.00 | +203.87% | Reiterates | 7 months ago |
Sarepta Therapeutics IncSRPT | 16 | Sell | $10.00 | -50.84% | Downgrades | 7 months ago |
Lyell Immunopharma IncLYEL | 13 | Hold | $10.00 | -58.33% | Maintains | 7 months ago |
Verve Therapeutics IncVERV | 7 | Hold | $13.50 | +21.29% | Downgrades | 7 months ago |
Intellia Therapeutics IncNTLA | 4 | Buy | $30.00 | +128.14% | Reiterates | 8 months ago |
Instil Bio IncTIL | 16 | Buy | $125.00 | +1,670.54% | Reiterates | 8 months ago |
Boundless Bio IncBOLD | 1 | Buy | $5.00 | +331.03% | Initiates Coverage On | 8 months ago |
Avalo Therapeutics IncAVTX | 1 | Buy | $15.00 | -0.73% | Assumes | 8 months ago |
Kyverna Therapeutics IncKYTX | 7 | Buy | $5.00 | -37.58% | Upgrades | 8 months ago |
Cytomx Therapeutics IncCTMX | 3 | Buy | $5.00 | -12.13% | Reiterates | 8 months ago |
Lexeo Therapeutics IncLXEO | 8 | Buy | $15.00 | +102.43% | Maintains | 9 months ago |
Neurogene IncNGNE | 15 | Buy | $45.00 | +154.81% | Maintains | 9 months ago |
Editas Medicine IncEDIT | 1 | Buy | $3.00 | +50.75% | Initiates Coverage On | 9 months ago |
Cartesian Therapeutics IncRNAC | 16 | Buy | $40.00 | +485.65% | Reiterates | 10 months ago |
Metagenomi IncMGX | 9 | Buy | $7.00 | +354.55% | Maintains | 10 months ago |
Zura Bio LtdZURA | 6 | Hold | $3.00 | -47.18% | Maintains | 10 months ago |
Rani Therapeutics Holdings IncRANI | 15 | Buy | $9.00 | +643.80% | Reiterates | 10 months ago |
Century Therapeutics IncIPSC | 16 | Buy | $2.00 | +5.26% | Maintains | 10 months ago |
Abeona Therapeutics IncABEO | 2 | Buy | $15.00 | +194.70% | Reiterates | 10 months ago |
Rallybio CorpRLYB | 19 | Buy | $5.00 | +678.82% | Reiterates | a year ago |
Tc Biopharm PLCTCBP | 3 | Buy | $48.00 | N/A | Maintains | a year ago |
Carisma Therapeutics IncCARM | 11 | Buy | $5.00 | N/A | Maintains | a year ago |
Onkure Therapeutics IncOKUR | 4 | Hold | $15.00 | N/A | Reiterates | 2 years ago |
Rain Oncology IncRAIN2 | 2 | Buy | $19.00 | N/A | Maintains | 3 years ago |
Imago Biosciences IncIMGO | 4 | Hold | $36.00 | N/A | Downgrades | 3 years ago |
Aditxt IncADTX | 1 | Buy | $180,800,000.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.